Miguel Forte

Miguel Forte is a prominent leader in the cell and gene therapy sector, currently serving as the Chief Executive Officer of Kiji Therapeutics, which specializes in engineered cell therapies for critical illnesses. With extensive experience in various roles at the International Society for Cell & Gene Therapy, including President and Vice-Chair of the Ethics Committee, Miguel Forte focuses on advancing the field through ethical practices and commercialization strategies. Additionally, Forte holds leadership positions at several organizations, such as the Executive Chair of StemBond Technologies and Founder and Managing Director of mC4Tx. Forte's educational background includes an MD from the University of Lisbon, a PhD in Medicine from the University of Birmingham, and further qualifications in Tropical Medicine and Pharmaceutical Medicine.